SupplementScore.org

Vitamin D and falls in older adults: the conflicting STURDY and VITAL trial record

6 min read · By the · Updated · How we research
Bottom Line

Vitamin D does not prevent falls or fractures in community-dwelling adults who are not deficient. STURDY found that pushing the dose higher (up to 4,000 IU/day) gave no benefit and a numerically higher fall rate. VITAL, in a largely replete population, found no reduction in falls or fractures. A 2026 BMJ meta-analysis of 69 trials and 153,902 adults not on an osteoporosis drug found the same pattern: vitamin D fracture risk ratio 1.00 (95% CI 0.95 to 1.06, high certainty) and little to no effect on falls (Massé et al., PMID 42161415, doi:10.1136/bmj-2025-088050). Calcium alone was 0.91 (0.81 to 1.01, moderate certainty). Most of those participants were community-dwelling. Use vitamin D to treat deficiency, at a modest daily dose, not as a fall or fracture pill. Anyone over 70 who is already supplementing and still falling needs a review of gait, vision, blood pressure, and medications.

What the early observational signal suggested

The original enthusiasm came from meta-analyses of small trials in the 2000s suggesting a 14–20% reduction in falls with vitamin D 800 IU/day in institutionalised older adults (PMID: 19797342).1 These were largely in vitamin D-deficient nursing home residents, and the magnitude of effect tracked closely with how deficient the baseline population was. The American Geriatrics Society incorporated this into a 2010 clinical practice guideline recommending routine 800 IU supplementation in adults aged 65 and over to prevent falls.

STURDY: more is not better

The STURDY trial, published in 2020, randomised 688 community-dwelling adults aged 70 and over with baseline 25(OH)D levels of 10–29 ng/mL to one of four doses of vitamin D3: 200, 1,000, 2,000, or 4,000 IU/day for two years.2 Compared with the 200 IU reference dose, the higher doses showed no reduction in time-to-first-fall and a numerically higher risk of falls at 1,000–4,000 IU. The trial was stopped early for futility and a possible safety signal. The conclusion — that escalating vitamin D dose did not produce escalating benefit — directly contradicted the dose-response logic that had driven over-the-counter formulations toward 5,000 and 10,000 IU capsules.

VITAL: no effect in the general population

VITAL randomised 25,871 adults aged 50 and over to 2,000 IU/day vitamin D3 or placebo for a median 5.3 years. The pre-specified ancillary analysis of falls and fractures, published in 2022, found no reduction in the rate of total fractures, hip fractures, or non-vertebral fractures.3 A separate fall analysis showed no effect on incidence of falls or injurious falls.4 Notably, this was a generally vitamin D-replete population — mean baseline 25(OH)D was 30 ng/mL — and supplementation could not reduce an event rate already at the population floor.

D-Health and high-dose monthly bolus

Combined with earlier signals that very large annual boluses can paradoxically increase fall rates (PMID: 20460620), the modern picture is that intermittent megadosing does not work and may harm.5

What the 2026 review concludes

Massé and colleagues pooled 69 randomised trials (153,902 adults, none receiving a drug for osteoporosis) of calcium, vitamin D, or both against placebo or no treatment (PMID 42161415; doi:10.1136/bmj-2025-088050).6 For any fracture, vitamin D’s risk ratio was 1.00 (95% CI 0.95 to 1.06; 36 trials, 92,045 people; high certainty). Calcium was 0.91 (0.81 to 1.01; 11 trials, 9,067 people; moderate certainty). Calcium plus vitamin D was 0.91 (0.84 to 0.99; 15 trials, 51,126 people; high certainty), and the authors judged that absolute difference not clinically meaningful. All three had little to no effect on falls. Eighty-seven percent of participants were community-dwelling and 73 percent were not at high risk. Evidence for high-risk patients and residential care was limited for many calcium-only and combined outcomes. For adults with deficiency, modest supplementation still treats the deficiency. It is not a fall-prevention programme for people who are already replete.

What this means for adults choosing a dose

A reasonable 2026 framework: test 25(OH)D before supplementing, correct levels under 20 ng/mL with 1,000–2,000 IU/day, and stop chasing higher targets without a clinical reason. The era of recommending 4,000 IU as a universal "longevity dose" is over. Anyone over 70 who is already supplementing and still falling should have their gait, vision, blood pressure, and medication list reviewed — falls in this age group are multifactorial, and a single nutrient was never the right lever.

Sources

  1. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. "Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials." BMJ, 2009;339:b3692. PMID: 19797342. DOI: 10.1136/bmj.b3692.
  2. Appel LJ, Michos ED, Mitchell CM, et al. "The effects of four doses of vitamin D supplements on falls in older adults: a response-adaptive, randomized clinical trial." Ann Intern Med, 2021;174(2):145-156. PMID: 33284677. DOI: 10.7326/M20-3812
  3. LeBoff MS, Chou SH, Ratliff KA, et al. "Supplemental vitamin D and incident fractures in midlife and older adults." N Engl J Med, 2022;387(4):299-309. PMID: 35939577. DOI: 10.1056/NEJMoa2202106
  4. LeBoff MS, Bischoff-Ferrari HA. "The effects of vitamin D supplementation on musculoskeletal health: the VITAL and DO-HEALTH trials." J Bone Miner Res, 2023;38(1):3-11. PMID: 37325962. DOI: 10.1093/gerona/glad073
  5. Sanders KM, Stuart AL, Williamson EJ, et al. "Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial." JAMA, 2010;303(18):1815-1822. PMID: 20460620. DOI: 10.1001/jama.2010.594.
  6. Massé O, Mercurio CM, Dupuis S, et al. "Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis." BMJ, 2026;393:e088050. PMID: 42161415. DOI: 10.1136/bmj-2025-088050.